ArticleMediators of inflammation2016

Interleukin-22 Might Act as a Double-Edged Sword in Type 2 Diabetes and Coronary Artery Disease.

Fangchen Gong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.